Reshape Lifesciences Inc (RSLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Operating Expenses | 5,970 | 6,071 | 6,319 | 6,760 | 5,573 |
| Operating Income | -5,970 | -6,071 | -6,319 | -6,760 | -5,573 |
| Interest Expense | 225 | 248 | 261 | 265 | 264 |
| Other Income | -108 | -4 | -1 | -1 | -11 |
| Pre-tax Income | -6,303 | -6,323 | -6,582 | -7,027 | -5,847 |
| Net Income Continuous | -6,303 | -6,323 | -6,582 | -7,027 | -5,847 |
| Net Income | $-6,303 | $-6,323 | $-6,582 | $-7,027 | $-5,847 |
| EPS Basic Total Ops | -0.11 | -0.11 | -0.14 | -0.17 | -0.14 |
| EPS Basic Continuous Ops | -0.11 | -0.11 | -0.14 | -0.17 | -0.14 |
| EPS Diluted Total Ops | -0.11 | -0.11 | -0.14 | -0.17 | -0.14 |
| EPS Diluted Continuous Ops | -0.11 | -0.11 | -0.14 | -0.17 | -0.14 |
| EBITDA(a) | $-5,879 | $-5,979 | $-6,223 | $-6,657 | $-5,467 |